Prime Minister Narendra Modi’s US visit was dubbed as a great bilateral victory for India… The sector in question is Intellectual Property Rights (IPR)… The leaders…talk about a high level bilateral working group on intellectual property... most dangerous aspect of the proposed committee that India has agreed to is the empowerment for decision-making…It was the existing IP policy that helped build India’s pharma industry, which now is the lifeline for not only the country’s healthcare needs, but also that of most of the developing world. This regime is extremely crucial for ensuring an enabling environment for the pharma industry because it is still not capable of developing new drugs on its own given the poor resources at its disposal.